BRAIN RES 润色咨询

BRAIN RESEARCH

出版年份:暂无数据 年文章数:16852 投稿命中率: 开通期刊会员,数据随心看

出版周期:Weekly 自引率:1.6% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2189408, encodeId=92572189408c8, content=观后感, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0b29186152, createdName=ms5000001014751680, createdTime=Mon Feb 26 10:27:54 CST 2024, time=2024-02-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2133882, encodeId=e5d7213388296, content=各位战友,投稿半个月 状态:Editor Decision Made ;是啥意思?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3bfb2283030, createdName=121ccd8dm34(暂无昵称), createdTime=Mon May 15 11:08:36 CST 2023, time=2023-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2174602, encodeId=77b521e4602d4, content=偏重的研究方向:行为学;神经保护<br>经验分享:一审大修,二审小修,修回去10天了,一直是received by editor是什么情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25825184447, createdName=14703350m46(暂无昵称), createdTime=Tue Dec 12 23:59:02 CST 2023, time=2023-12-12, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2093767, encodeId=44d02093e6747, content=偏重的研究方向:肿瘤<br>经验分享:脑癌可以投稿这个杂质吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf0d8109013, createdName=ms1000000582200464, createdTime=Fri Oct 14 13:57:43 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153280, encodeId=f1f4215328031, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:神经行为学;糖尿病<br>经验分享:2023.08.06 投稿<br>2023.08.07 Received by Editor<br>2023.08.17 Received by Editor<br>好焦灼啊,在编辑那里已经10天了,一直在编辑手里,还能送审吗,各位朋友们也是这样吗,希望大神指点迷津,谢谢🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bbd8178407, createdName=ms3000001512295561, createdTime=Thu Aug 17 18:46:59 CST 2023, time=2023-08-17, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2159619, encodeId=e36821596198d, content=审稿速度:1.0<br>经验分享:还行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e5a8814532, createdName=ms9000000940325280, createdTime=Mon Sep 25 18:19:02 CST 2023, time=2023-09-25, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2139419, encodeId=9987213941961, content=偏重的研究方向:fMRI<br>经验分享:请问大家in reviewer agreement多久可以发邮件问问啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd798162227, createdName=ms5000001864785048, createdTime=Sat May 27 21:08:49 CST 2023, time=2023-05-27, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1055489, encodeId=ca43105548971, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:神经科学;神经保护;行为学研究<br>经验分享:审稿速度还可以,一审三个审稿人,每个人都提出比较犀利的问题,一审修回去的时候,认真回复每一个审稿人的问题,总体上还算快,赶上明年毕业了。 2021.07.02 subit to journal 2021.07.03 received by editor 2021.07.05 reviewer contacted 2021.07.10 in reviewer agreement 2021.07.21 reviews complete 2021.07.27一审回来 2021.09.01 revised 2021.09.23 accept 2021.09.27 online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210721/35d314b5314d46aba1e20be6d739910e/47473a0e9fe8466c9339b238c83a22d4.jpg, createdBy=6efd5395144, createdName=Jason2021, createdTime=Mon Sep 27 20:54:24 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2130043, encodeId=ee1d2130043af, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享:2023.02.01-2023.05.03,三个月接收,审稿人很专业、认真,不错的期刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKPeeEwPQq9TASVuAByxCR5o85FHJwY4Tiae5lKJUib7yAmric9Gic4wuw6mhEdxX37O8ZOic3fXedyLNQ/132, createdBy=6fb81469253, createdName=mxl7125, createdTime=Thu May 04 13:49:28 CST 2023, time=2023-05-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1187443, encodeId=1e06118e44354, content=各位战友:<br>submit 2022-1-10<br>in reviewer agreement 2022-1-10<br>reviews complete 2022-1-23<br>请问一下什么时候可以出一审意见啊? 希望有好运🍀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75925387539, createdName=ms4000000145395898, createdTime=Sun Jan 23 12:31:38 CST 2022, time=2022-01-23, status=1, ipAttribution=)]
    2024-02-26 ms5000001014751680 来自北京

    观后感

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2189408, encodeId=92572189408c8, content=观后感, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0b29186152, createdName=ms5000001014751680, createdTime=Mon Feb 26 10:27:54 CST 2024, time=2024-02-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2133882, encodeId=e5d7213388296, content=各位战友,投稿半个月 状态:Editor Decision Made ;是啥意思?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3bfb2283030, createdName=121ccd8dm34(暂无昵称), createdTime=Mon May 15 11:08:36 CST 2023, time=2023-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2174602, encodeId=77b521e4602d4, content=偏重的研究方向:行为学;神经保护<br>经验分享:一审大修,二审小修,修回去10天了,一直是received by editor是什么情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25825184447, createdName=14703350m46(暂无昵称), createdTime=Tue Dec 12 23:59:02 CST 2023, time=2023-12-12, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2093767, encodeId=44d02093e6747, content=偏重的研究方向:肿瘤<br>经验分享:脑癌可以投稿这个杂质吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf0d8109013, createdName=ms1000000582200464, createdTime=Fri Oct 14 13:57:43 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153280, encodeId=f1f4215328031, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:神经行为学;糖尿病<br>经验分享:2023.08.06 投稿<br>2023.08.07 Received by Editor<br>2023.08.17 Received by Editor<br>好焦灼啊,在编辑那里已经10天了,一直在编辑手里,还能送审吗,各位朋友们也是这样吗,希望大神指点迷津,谢谢🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bbd8178407, createdName=ms3000001512295561, createdTime=Thu Aug 17 18:46:59 CST 2023, time=2023-08-17, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2159619, encodeId=e36821596198d, content=审稿速度:1.0<br>经验分享:还行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e5a8814532, createdName=ms9000000940325280, createdTime=Mon Sep 25 18:19:02 CST 2023, time=2023-09-25, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2139419, encodeId=9987213941961, content=偏重的研究方向:fMRI<br>经验分享:请问大家in reviewer agreement多久可以发邮件问问啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd798162227, createdName=ms5000001864785048, createdTime=Sat May 27 21:08:49 CST 2023, time=2023-05-27, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1055489, encodeId=ca43105548971, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:神经科学;神经保护;行为学研究<br>经验分享:审稿速度还可以,一审三个审稿人,每个人都提出比较犀利的问题,一审修回去的时候,认真回复每一个审稿人的问题,总体上还算快,赶上明年毕业了。 2021.07.02 subit to journal 2021.07.03 received by editor 2021.07.05 reviewer contacted 2021.07.10 in reviewer agreement 2021.07.21 reviews complete 2021.07.27一审回来 2021.09.01 revised 2021.09.23 accept 2021.09.27 online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210721/35d314b5314d46aba1e20be6d739910e/47473a0e9fe8466c9339b238c83a22d4.jpg, createdBy=6efd5395144, createdName=Jason2021, createdTime=Mon Sep 27 20:54:24 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2130043, encodeId=ee1d2130043af, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享:2023.02.01-2023.05.03,三个月接收,审稿人很专业、认真,不错的期刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKPeeEwPQq9TASVuAByxCR5o85FHJwY4Tiae5lKJUib7yAmric9Gic4wuw6mhEdxX37O8ZOic3fXedyLNQ/132, createdBy=6fb81469253, createdName=mxl7125, createdTime=Thu May 04 13:49:28 CST 2023, time=2023-05-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1187443, encodeId=1e06118e44354, content=各位战友:<br>submit 2022-1-10<br>in reviewer agreement 2022-1-10<br>reviews complete 2022-1-23<br>请问一下什么时候可以出一审意见啊? 希望有好运🍀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75925387539, createdName=ms4000000145395898, createdTime=Sun Jan 23 12:31:38 CST 2022, time=2022-01-23, status=1, ipAttribution=)]
    2023-05-15 121ccd8dm34(暂无昵称)

    各位战友,投稿半个月 状态:Editor Decision Made ;是啥意思?

    7

    展开7条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2189408, encodeId=92572189408c8, content=观后感, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0b29186152, createdName=ms5000001014751680, createdTime=Mon Feb 26 10:27:54 CST 2024, time=2024-02-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2133882, encodeId=e5d7213388296, content=各位战友,投稿半个月 状态:Editor Decision Made ;是啥意思?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3bfb2283030, createdName=121ccd8dm34(暂无昵称), createdTime=Mon May 15 11:08:36 CST 2023, time=2023-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2174602, encodeId=77b521e4602d4, content=偏重的研究方向:行为学;神经保护<br>经验分享:一审大修,二审小修,修回去10天了,一直是received by editor是什么情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25825184447, createdName=14703350m46(暂无昵称), createdTime=Tue Dec 12 23:59:02 CST 2023, time=2023-12-12, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2093767, encodeId=44d02093e6747, content=偏重的研究方向:肿瘤<br>经验分享:脑癌可以投稿这个杂质吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf0d8109013, createdName=ms1000000582200464, createdTime=Fri Oct 14 13:57:43 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153280, encodeId=f1f4215328031, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:神经行为学;糖尿病<br>经验分享:2023.08.06 投稿<br>2023.08.07 Received by Editor<br>2023.08.17 Received by Editor<br>好焦灼啊,在编辑那里已经10天了,一直在编辑手里,还能送审吗,各位朋友们也是这样吗,希望大神指点迷津,谢谢🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bbd8178407, createdName=ms3000001512295561, createdTime=Thu Aug 17 18:46:59 CST 2023, time=2023-08-17, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2159619, encodeId=e36821596198d, content=审稿速度:1.0<br>经验分享:还行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e5a8814532, createdName=ms9000000940325280, createdTime=Mon Sep 25 18:19:02 CST 2023, time=2023-09-25, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2139419, encodeId=9987213941961, content=偏重的研究方向:fMRI<br>经验分享:请问大家in reviewer agreement多久可以发邮件问问啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd798162227, createdName=ms5000001864785048, createdTime=Sat May 27 21:08:49 CST 2023, time=2023-05-27, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1055489, encodeId=ca43105548971, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:神经科学;神经保护;行为学研究<br>经验分享:审稿速度还可以,一审三个审稿人,每个人都提出比较犀利的问题,一审修回去的时候,认真回复每一个审稿人的问题,总体上还算快,赶上明年毕业了。 2021.07.02 subit to journal 2021.07.03 received by editor 2021.07.05 reviewer contacted 2021.07.10 in reviewer agreement 2021.07.21 reviews complete 2021.07.27一审回来 2021.09.01 revised 2021.09.23 accept 2021.09.27 online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210721/35d314b5314d46aba1e20be6d739910e/47473a0e9fe8466c9339b238c83a22d4.jpg, createdBy=6efd5395144, createdName=Jason2021, createdTime=Mon Sep 27 20:54:24 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2130043, encodeId=ee1d2130043af, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享:2023.02.01-2023.05.03,三个月接收,审稿人很专业、认真,不错的期刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKPeeEwPQq9TASVuAByxCR5o85FHJwY4Tiae5lKJUib7yAmric9Gic4wuw6mhEdxX37O8ZOic3fXedyLNQ/132, createdBy=6fb81469253, createdName=mxl7125, createdTime=Thu May 04 13:49:28 CST 2023, time=2023-05-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1187443, encodeId=1e06118e44354, content=各位战友:<br>submit 2022-1-10<br>in reviewer agreement 2022-1-10<br>reviews complete 2022-1-23<br>请问一下什么时候可以出一审意见啊? 希望有好运🍀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75925387539, createdName=ms4000000145395898, createdTime=Sun Jan 23 12:31:38 CST 2022, time=2022-01-23, status=1, ipAttribution=)]
    2023-12-12 14703350m46(暂无昵称) 来自天津

    偏重的研究方向:行为学;神经保护
    经验分享:一审大修,二审小修,修回去10天了,一直是received by editor是什么情况啊

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2189408, encodeId=92572189408c8, content=观后感, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0b29186152, createdName=ms5000001014751680, createdTime=Mon Feb 26 10:27:54 CST 2024, time=2024-02-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2133882, encodeId=e5d7213388296, content=各位战友,投稿半个月 状态:Editor Decision Made ;是啥意思?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3bfb2283030, createdName=121ccd8dm34(暂无昵称), createdTime=Mon May 15 11:08:36 CST 2023, time=2023-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2174602, encodeId=77b521e4602d4, content=偏重的研究方向:行为学;神经保护<br>经验分享:一审大修,二审小修,修回去10天了,一直是received by editor是什么情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25825184447, createdName=14703350m46(暂无昵称), createdTime=Tue Dec 12 23:59:02 CST 2023, time=2023-12-12, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2093767, encodeId=44d02093e6747, content=偏重的研究方向:肿瘤<br>经验分享:脑癌可以投稿这个杂质吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf0d8109013, createdName=ms1000000582200464, createdTime=Fri Oct 14 13:57:43 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153280, encodeId=f1f4215328031, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:神经行为学;糖尿病<br>经验分享:2023.08.06 投稿<br>2023.08.07 Received by Editor<br>2023.08.17 Received by Editor<br>好焦灼啊,在编辑那里已经10天了,一直在编辑手里,还能送审吗,各位朋友们也是这样吗,希望大神指点迷津,谢谢🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bbd8178407, createdName=ms3000001512295561, createdTime=Thu Aug 17 18:46:59 CST 2023, time=2023-08-17, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2159619, encodeId=e36821596198d, content=审稿速度:1.0<br>经验分享:还行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e5a8814532, createdName=ms9000000940325280, createdTime=Mon Sep 25 18:19:02 CST 2023, time=2023-09-25, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2139419, encodeId=9987213941961, content=偏重的研究方向:fMRI<br>经验分享:请问大家in reviewer agreement多久可以发邮件问问啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd798162227, createdName=ms5000001864785048, createdTime=Sat May 27 21:08:49 CST 2023, time=2023-05-27, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1055489, encodeId=ca43105548971, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:神经科学;神经保护;行为学研究<br>经验分享:审稿速度还可以,一审三个审稿人,每个人都提出比较犀利的问题,一审修回去的时候,认真回复每一个审稿人的问题,总体上还算快,赶上明年毕业了。 2021.07.02 subit to journal 2021.07.03 received by editor 2021.07.05 reviewer contacted 2021.07.10 in reviewer agreement 2021.07.21 reviews complete 2021.07.27一审回来 2021.09.01 revised 2021.09.23 accept 2021.09.27 online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210721/35d314b5314d46aba1e20be6d739910e/47473a0e9fe8466c9339b238c83a22d4.jpg, createdBy=6efd5395144, createdName=Jason2021, createdTime=Mon Sep 27 20:54:24 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2130043, encodeId=ee1d2130043af, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享:2023.02.01-2023.05.03,三个月接收,审稿人很专业、认真,不错的期刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKPeeEwPQq9TASVuAByxCR5o85FHJwY4Tiae5lKJUib7yAmric9Gic4wuw6mhEdxX37O8ZOic3fXedyLNQ/132, createdBy=6fb81469253, createdName=mxl7125, createdTime=Thu May 04 13:49:28 CST 2023, time=2023-05-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1187443, encodeId=1e06118e44354, content=各位战友:<br>submit 2022-1-10<br>in reviewer agreement 2022-1-10<br>reviews complete 2022-1-23<br>请问一下什么时候可以出一审意见啊? 希望有好运🍀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75925387539, createdName=ms4000000145395898, createdTime=Sun Jan 23 12:31:38 CST 2022, time=2022-01-23, status=1, ipAttribution=)]
    2022-10-14 ms1000000582200464

    偏重的研究方向:肿瘤
    经验分享:脑癌可以投稿这个杂质吗

    1

    展开1条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2189408, encodeId=92572189408c8, content=观后感, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0b29186152, createdName=ms5000001014751680, createdTime=Mon Feb 26 10:27:54 CST 2024, time=2024-02-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2133882, encodeId=e5d7213388296, content=各位战友,投稿半个月 状态:Editor Decision Made ;是啥意思?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3bfb2283030, createdName=121ccd8dm34(暂无昵称), createdTime=Mon May 15 11:08:36 CST 2023, time=2023-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2174602, encodeId=77b521e4602d4, content=偏重的研究方向:行为学;神经保护<br>经验分享:一审大修,二审小修,修回去10天了,一直是received by editor是什么情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25825184447, createdName=14703350m46(暂无昵称), createdTime=Tue Dec 12 23:59:02 CST 2023, time=2023-12-12, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2093767, encodeId=44d02093e6747, content=偏重的研究方向:肿瘤<br>经验分享:脑癌可以投稿这个杂质吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf0d8109013, createdName=ms1000000582200464, createdTime=Fri Oct 14 13:57:43 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153280, encodeId=f1f4215328031, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:神经行为学;糖尿病<br>经验分享:2023.08.06 投稿<br>2023.08.07 Received by Editor<br>2023.08.17 Received by Editor<br>好焦灼啊,在编辑那里已经10天了,一直在编辑手里,还能送审吗,各位朋友们也是这样吗,希望大神指点迷津,谢谢🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bbd8178407, createdName=ms3000001512295561, createdTime=Thu Aug 17 18:46:59 CST 2023, time=2023-08-17, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2159619, encodeId=e36821596198d, content=审稿速度:1.0<br>经验分享:还行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e5a8814532, createdName=ms9000000940325280, createdTime=Mon Sep 25 18:19:02 CST 2023, time=2023-09-25, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2139419, encodeId=9987213941961, content=偏重的研究方向:fMRI<br>经验分享:请问大家in reviewer agreement多久可以发邮件问问啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd798162227, createdName=ms5000001864785048, createdTime=Sat May 27 21:08:49 CST 2023, time=2023-05-27, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1055489, encodeId=ca43105548971, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:神经科学;神经保护;行为学研究<br>经验分享:审稿速度还可以,一审三个审稿人,每个人都提出比较犀利的问题,一审修回去的时候,认真回复每一个审稿人的问题,总体上还算快,赶上明年毕业了。 2021.07.02 subit to journal 2021.07.03 received by editor 2021.07.05 reviewer contacted 2021.07.10 in reviewer agreement 2021.07.21 reviews complete 2021.07.27一审回来 2021.09.01 revised 2021.09.23 accept 2021.09.27 online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210721/35d314b5314d46aba1e20be6d739910e/47473a0e9fe8466c9339b238c83a22d4.jpg, createdBy=6efd5395144, createdName=Jason2021, createdTime=Mon Sep 27 20:54:24 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2130043, encodeId=ee1d2130043af, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享:2023.02.01-2023.05.03,三个月接收,审稿人很专业、认真,不错的期刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKPeeEwPQq9TASVuAByxCR5o85FHJwY4Tiae5lKJUib7yAmric9Gic4wuw6mhEdxX37O8ZOic3fXedyLNQ/132, createdBy=6fb81469253, createdName=mxl7125, createdTime=Thu May 04 13:49:28 CST 2023, time=2023-05-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1187443, encodeId=1e06118e44354, content=各位战友:<br>submit 2022-1-10<br>in reviewer agreement 2022-1-10<br>reviews complete 2022-1-23<br>请问一下什么时候可以出一审意见啊? 希望有好运🍀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75925387539, createdName=ms4000000145395898, createdTime=Sun Jan 23 12:31:38 CST 2022, time=2022-01-23, status=1, ipAttribution=)]
    2023-08-17 ms3000001512295561 来自浙江省

    审稿速度:2.0 | 投稿命中率:50.0
    偏重的研究方向:神经行为学;糖尿病
    经验分享:2023.08.06 投稿
    2023.08.07 Received by Editor
    2023.08.17 Received by Editor
    好焦灼啊,在编辑那里已经10天了,一直在编辑手里,还能送审吗,各位朋友们也是这样吗,希望大神指点迷津,谢谢🙏

    6

    展开6条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2189408, encodeId=92572189408c8, content=观后感, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0b29186152, createdName=ms5000001014751680, createdTime=Mon Feb 26 10:27:54 CST 2024, time=2024-02-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2133882, encodeId=e5d7213388296, content=各位战友,投稿半个月 状态:Editor Decision Made ;是啥意思?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3bfb2283030, createdName=121ccd8dm34(暂无昵称), createdTime=Mon May 15 11:08:36 CST 2023, time=2023-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2174602, encodeId=77b521e4602d4, content=偏重的研究方向:行为学;神经保护<br>经验分享:一审大修,二审小修,修回去10天了,一直是received by editor是什么情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25825184447, createdName=14703350m46(暂无昵称), createdTime=Tue Dec 12 23:59:02 CST 2023, time=2023-12-12, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2093767, encodeId=44d02093e6747, content=偏重的研究方向:肿瘤<br>经验分享:脑癌可以投稿这个杂质吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf0d8109013, createdName=ms1000000582200464, createdTime=Fri Oct 14 13:57:43 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153280, encodeId=f1f4215328031, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:神经行为学;糖尿病<br>经验分享:2023.08.06 投稿<br>2023.08.07 Received by Editor<br>2023.08.17 Received by Editor<br>好焦灼啊,在编辑那里已经10天了,一直在编辑手里,还能送审吗,各位朋友们也是这样吗,希望大神指点迷津,谢谢🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bbd8178407, createdName=ms3000001512295561, createdTime=Thu Aug 17 18:46:59 CST 2023, time=2023-08-17, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2159619, encodeId=e36821596198d, content=审稿速度:1.0<br>经验分享:还行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e5a8814532, createdName=ms9000000940325280, createdTime=Mon Sep 25 18:19:02 CST 2023, time=2023-09-25, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2139419, encodeId=9987213941961, content=偏重的研究方向:fMRI<br>经验分享:请问大家in reviewer agreement多久可以发邮件问问啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd798162227, createdName=ms5000001864785048, createdTime=Sat May 27 21:08:49 CST 2023, time=2023-05-27, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1055489, encodeId=ca43105548971, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:神经科学;神经保护;行为学研究<br>经验分享:审稿速度还可以,一审三个审稿人,每个人都提出比较犀利的问题,一审修回去的时候,认真回复每一个审稿人的问题,总体上还算快,赶上明年毕业了。 2021.07.02 subit to journal 2021.07.03 received by editor 2021.07.05 reviewer contacted 2021.07.10 in reviewer agreement 2021.07.21 reviews complete 2021.07.27一审回来 2021.09.01 revised 2021.09.23 accept 2021.09.27 online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210721/35d314b5314d46aba1e20be6d739910e/47473a0e9fe8466c9339b238c83a22d4.jpg, createdBy=6efd5395144, createdName=Jason2021, createdTime=Mon Sep 27 20:54:24 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2130043, encodeId=ee1d2130043af, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享:2023.02.01-2023.05.03,三个月接收,审稿人很专业、认真,不错的期刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKPeeEwPQq9TASVuAByxCR5o85FHJwY4Tiae5lKJUib7yAmric9Gic4wuw6mhEdxX37O8ZOic3fXedyLNQ/132, createdBy=6fb81469253, createdName=mxl7125, createdTime=Thu May 04 13:49:28 CST 2023, time=2023-05-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1187443, encodeId=1e06118e44354, content=各位战友:<br>submit 2022-1-10<br>in reviewer agreement 2022-1-10<br>reviews complete 2022-1-23<br>请问一下什么时候可以出一审意见啊? 希望有好运🍀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75925387539, createdName=ms4000000145395898, createdTime=Sun Jan 23 12:31:38 CST 2022, time=2022-01-23, status=1, ipAttribution=)]
    2023-09-25 ms9000000940325280 来自湖北省

    审稿速度:1.0
    经验分享:还行

    1

    展开1条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2189408, encodeId=92572189408c8, content=观后感, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0b29186152, createdName=ms5000001014751680, createdTime=Mon Feb 26 10:27:54 CST 2024, time=2024-02-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2133882, encodeId=e5d7213388296, content=各位战友,投稿半个月 状态:Editor Decision Made ;是啥意思?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3bfb2283030, createdName=121ccd8dm34(暂无昵称), createdTime=Mon May 15 11:08:36 CST 2023, time=2023-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2174602, encodeId=77b521e4602d4, content=偏重的研究方向:行为学;神经保护<br>经验分享:一审大修,二审小修,修回去10天了,一直是received by editor是什么情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25825184447, createdName=14703350m46(暂无昵称), createdTime=Tue Dec 12 23:59:02 CST 2023, time=2023-12-12, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2093767, encodeId=44d02093e6747, content=偏重的研究方向:肿瘤<br>经验分享:脑癌可以投稿这个杂质吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf0d8109013, createdName=ms1000000582200464, createdTime=Fri Oct 14 13:57:43 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153280, encodeId=f1f4215328031, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:神经行为学;糖尿病<br>经验分享:2023.08.06 投稿<br>2023.08.07 Received by Editor<br>2023.08.17 Received by Editor<br>好焦灼啊,在编辑那里已经10天了,一直在编辑手里,还能送审吗,各位朋友们也是这样吗,希望大神指点迷津,谢谢🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bbd8178407, createdName=ms3000001512295561, createdTime=Thu Aug 17 18:46:59 CST 2023, time=2023-08-17, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2159619, encodeId=e36821596198d, content=审稿速度:1.0<br>经验分享:还行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e5a8814532, createdName=ms9000000940325280, createdTime=Mon Sep 25 18:19:02 CST 2023, time=2023-09-25, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2139419, encodeId=9987213941961, content=偏重的研究方向:fMRI<br>经验分享:请问大家in reviewer agreement多久可以发邮件问问啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd798162227, createdName=ms5000001864785048, createdTime=Sat May 27 21:08:49 CST 2023, time=2023-05-27, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1055489, encodeId=ca43105548971, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:神经科学;神经保护;行为学研究<br>经验分享:审稿速度还可以,一审三个审稿人,每个人都提出比较犀利的问题,一审修回去的时候,认真回复每一个审稿人的问题,总体上还算快,赶上明年毕业了。 2021.07.02 subit to journal 2021.07.03 received by editor 2021.07.05 reviewer contacted 2021.07.10 in reviewer agreement 2021.07.21 reviews complete 2021.07.27一审回来 2021.09.01 revised 2021.09.23 accept 2021.09.27 online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210721/35d314b5314d46aba1e20be6d739910e/47473a0e9fe8466c9339b238c83a22d4.jpg, createdBy=6efd5395144, createdName=Jason2021, createdTime=Mon Sep 27 20:54:24 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2130043, encodeId=ee1d2130043af, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享:2023.02.01-2023.05.03,三个月接收,审稿人很专业、认真,不错的期刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKPeeEwPQq9TASVuAByxCR5o85FHJwY4Tiae5lKJUib7yAmric9Gic4wuw6mhEdxX37O8ZOic3fXedyLNQ/132, createdBy=6fb81469253, createdName=mxl7125, createdTime=Thu May 04 13:49:28 CST 2023, time=2023-05-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1187443, encodeId=1e06118e44354, content=各位战友:<br>submit 2022-1-10<br>in reviewer agreement 2022-1-10<br>reviews complete 2022-1-23<br>请问一下什么时候可以出一审意见啊? 希望有好运🍀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75925387539, createdName=ms4000000145395898, createdTime=Sun Jan 23 12:31:38 CST 2022, time=2022-01-23, status=1, ipAttribution=)]
    2023-05-27 ms5000001864785048 来自广西

    偏重的研究方向:fMRI
    经验分享:请问大家in reviewer agreement多久可以发邮件问问啊

    2

    展开2条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2189408, encodeId=92572189408c8, content=观后感, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0b29186152, createdName=ms5000001014751680, createdTime=Mon Feb 26 10:27:54 CST 2024, time=2024-02-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2133882, encodeId=e5d7213388296, content=各位战友,投稿半个月 状态:Editor Decision Made ;是啥意思?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3bfb2283030, createdName=121ccd8dm34(暂无昵称), createdTime=Mon May 15 11:08:36 CST 2023, time=2023-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2174602, encodeId=77b521e4602d4, content=偏重的研究方向:行为学;神经保护<br>经验分享:一审大修,二审小修,修回去10天了,一直是received by editor是什么情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25825184447, createdName=14703350m46(暂无昵称), createdTime=Tue Dec 12 23:59:02 CST 2023, time=2023-12-12, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2093767, encodeId=44d02093e6747, content=偏重的研究方向:肿瘤<br>经验分享:脑癌可以投稿这个杂质吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf0d8109013, createdName=ms1000000582200464, createdTime=Fri Oct 14 13:57:43 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153280, encodeId=f1f4215328031, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:神经行为学;糖尿病<br>经验分享:2023.08.06 投稿<br>2023.08.07 Received by Editor<br>2023.08.17 Received by Editor<br>好焦灼啊,在编辑那里已经10天了,一直在编辑手里,还能送审吗,各位朋友们也是这样吗,希望大神指点迷津,谢谢🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bbd8178407, createdName=ms3000001512295561, createdTime=Thu Aug 17 18:46:59 CST 2023, time=2023-08-17, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2159619, encodeId=e36821596198d, content=审稿速度:1.0<br>经验分享:还行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e5a8814532, createdName=ms9000000940325280, createdTime=Mon Sep 25 18:19:02 CST 2023, time=2023-09-25, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2139419, encodeId=9987213941961, content=偏重的研究方向:fMRI<br>经验分享:请问大家in reviewer agreement多久可以发邮件问问啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd798162227, createdName=ms5000001864785048, createdTime=Sat May 27 21:08:49 CST 2023, time=2023-05-27, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1055489, encodeId=ca43105548971, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:神经科学;神经保护;行为学研究<br>经验分享:审稿速度还可以,一审三个审稿人,每个人都提出比较犀利的问题,一审修回去的时候,认真回复每一个审稿人的问题,总体上还算快,赶上明年毕业了。 2021.07.02 subit to journal 2021.07.03 received by editor 2021.07.05 reviewer contacted 2021.07.10 in reviewer agreement 2021.07.21 reviews complete 2021.07.27一审回来 2021.09.01 revised 2021.09.23 accept 2021.09.27 online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210721/35d314b5314d46aba1e20be6d739910e/47473a0e9fe8466c9339b238c83a22d4.jpg, createdBy=6efd5395144, createdName=Jason2021, createdTime=Mon Sep 27 20:54:24 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2130043, encodeId=ee1d2130043af, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享:2023.02.01-2023.05.03,三个月接收,审稿人很专业、认真,不错的期刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKPeeEwPQq9TASVuAByxCR5o85FHJwY4Tiae5lKJUib7yAmric9Gic4wuw6mhEdxX37O8ZOic3fXedyLNQ/132, createdBy=6fb81469253, createdName=mxl7125, createdTime=Thu May 04 13:49:28 CST 2023, time=2023-05-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1187443, encodeId=1e06118e44354, content=各位战友:<br>submit 2022-1-10<br>in reviewer agreement 2022-1-10<br>reviews complete 2022-1-23<br>请问一下什么时候可以出一审意见啊? 希望有好运🍀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75925387539, createdName=ms4000000145395898, createdTime=Sun Jan 23 12:31:38 CST 2022, time=2022-01-23, status=1, ipAttribution=)]
    2021-09-27 Jason2021

    审稿速度:1.0 | 投稿命中率:50.0
    偏重的研究方向:神经科学;神经保护;行为学研究
    经验分享:审稿速度还可以,一审三个审稿人,每个人都提出比较犀利的问题,一审修回去的时候,认真回复每一个审稿人的问题,总体上还算快,赶上明年毕业了。 2021.07.02 subit to journal 2021.07.03 received by editor 2021.07.05 reviewer contacted 2021.07.10 in reviewer agreement 2021.07.21 reviews complete 2021.07.27一审回来 2021.09.01 revised 2021.09.23 accept 2021.09.27 online

    4

    展开4条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2189408, encodeId=92572189408c8, content=观后感, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0b29186152, createdName=ms5000001014751680, createdTime=Mon Feb 26 10:27:54 CST 2024, time=2024-02-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2133882, encodeId=e5d7213388296, content=各位战友,投稿半个月 状态:Editor Decision Made ;是啥意思?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3bfb2283030, createdName=121ccd8dm34(暂无昵称), createdTime=Mon May 15 11:08:36 CST 2023, time=2023-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2174602, encodeId=77b521e4602d4, content=偏重的研究方向:行为学;神经保护<br>经验分享:一审大修,二审小修,修回去10天了,一直是received by editor是什么情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25825184447, createdName=14703350m46(暂无昵称), createdTime=Tue Dec 12 23:59:02 CST 2023, time=2023-12-12, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2093767, encodeId=44d02093e6747, content=偏重的研究方向:肿瘤<br>经验分享:脑癌可以投稿这个杂质吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf0d8109013, createdName=ms1000000582200464, createdTime=Fri Oct 14 13:57:43 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153280, encodeId=f1f4215328031, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:神经行为学;糖尿病<br>经验分享:2023.08.06 投稿<br>2023.08.07 Received by Editor<br>2023.08.17 Received by Editor<br>好焦灼啊,在编辑那里已经10天了,一直在编辑手里,还能送审吗,各位朋友们也是这样吗,希望大神指点迷津,谢谢🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bbd8178407, createdName=ms3000001512295561, createdTime=Thu Aug 17 18:46:59 CST 2023, time=2023-08-17, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2159619, encodeId=e36821596198d, content=审稿速度:1.0<br>经验分享:还行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e5a8814532, createdName=ms9000000940325280, createdTime=Mon Sep 25 18:19:02 CST 2023, time=2023-09-25, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2139419, encodeId=9987213941961, content=偏重的研究方向:fMRI<br>经验分享:请问大家in reviewer agreement多久可以发邮件问问啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd798162227, createdName=ms5000001864785048, createdTime=Sat May 27 21:08:49 CST 2023, time=2023-05-27, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1055489, encodeId=ca43105548971, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:神经科学;神经保护;行为学研究<br>经验分享:审稿速度还可以,一审三个审稿人,每个人都提出比较犀利的问题,一审修回去的时候,认真回复每一个审稿人的问题,总体上还算快,赶上明年毕业了。 2021.07.02 subit to journal 2021.07.03 received by editor 2021.07.05 reviewer contacted 2021.07.10 in reviewer agreement 2021.07.21 reviews complete 2021.07.27一审回来 2021.09.01 revised 2021.09.23 accept 2021.09.27 online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210721/35d314b5314d46aba1e20be6d739910e/47473a0e9fe8466c9339b238c83a22d4.jpg, createdBy=6efd5395144, createdName=Jason2021, createdTime=Mon Sep 27 20:54:24 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2130043, encodeId=ee1d2130043af, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享:2023.02.01-2023.05.03,三个月接收,审稿人很专业、认真,不错的期刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKPeeEwPQq9TASVuAByxCR5o85FHJwY4Tiae5lKJUib7yAmric9Gic4wuw6mhEdxX37O8ZOic3fXedyLNQ/132, createdBy=6fb81469253, createdName=mxl7125, createdTime=Thu May 04 13:49:28 CST 2023, time=2023-05-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1187443, encodeId=1e06118e44354, content=各位战友:<br>submit 2022-1-10<br>in reviewer agreement 2022-1-10<br>reviews complete 2022-1-23<br>请问一下什么时候可以出一审意见啊? 希望有好运🍀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75925387539, createdName=ms4000000145395898, createdTime=Sun Jan 23 12:31:38 CST 2022, time=2022-01-23, status=1, ipAttribution=)]
    2023-05-04 mxl7125 来自山东省

    审稿速度:3.0 | 投稿命中率:75.0
    经验分享:2023.02.01-2023.05.03,三个月接收,审稿人很专业、认真,不错的期刊。

    1

    展开1条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2189408, encodeId=92572189408c8, content=观后感, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e0b29186152, createdName=ms5000001014751680, createdTime=Mon Feb 26 10:27:54 CST 2024, time=2024-02-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2133882, encodeId=e5d7213388296, content=各位战友,投稿半个月 状态:Editor Decision Made ;是啥意思?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3bfb2283030, createdName=121ccd8dm34(暂无昵称), createdTime=Mon May 15 11:08:36 CST 2023, time=2023-05-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2174602, encodeId=77b521e4602d4, content=偏重的研究方向:行为学;神经保护<br>经验分享:一审大修,二审小修,修回去10天了,一直是received by editor是什么情况啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=16, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=25825184447, createdName=14703350m46(暂无昵称), createdTime=Tue Dec 12 23:59:02 CST 2023, time=2023-12-12, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=2093767, encodeId=44d02093e6747, content=偏重的研究方向:肿瘤<br>经验分享:脑癌可以投稿这个杂质吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cf0d8109013, createdName=ms1000000582200464, createdTime=Fri Oct 14 13:57:43 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2153280, encodeId=f1f4215328031, content=审稿速度:2.0 | 投稿命中率:50.0<br>偏重的研究方向:神经行为学;糖尿病<br>经验分享:2023.08.06 投稿<br>2023.08.07 Received by Editor<br>2023.08.17 Received by Editor<br>好焦灼啊,在编辑那里已经10天了,一直在编辑手里,还能送审吗,各位朋友们也是这样吗,希望大神指点迷津,谢谢🙏, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3bbd8178407, createdName=ms3000001512295561, createdTime=Thu Aug 17 18:46:59 CST 2023, time=2023-08-17, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2159619, encodeId=e36821596198d, content=审稿速度:1.0<br>经验分享:还行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1e5a8814532, createdName=ms9000000940325280, createdTime=Mon Sep 25 18:19:02 CST 2023, time=2023-09-25, status=1, ipAttribution=湖北省), GetPortalCommentsPageByObjectIdResponse(id=2139419, encodeId=9987213941961, content=偏重的研究方向:fMRI<br>经验分享:请问大家in reviewer agreement多久可以发邮件问问啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd798162227, createdName=ms5000001864785048, createdTime=Sat May 27 21:08:49 CST 2023, time=2023-05-27, status=1, ipAttribution=广西), GetPortalCommentsPageByObjectIdResponse(id=1055489, encodeId=ca43105548971, content=审稿速度:1.0 | 投稿命中率:50.0<br>偏重的研究方向:神经科学;神经保护;行为学研究<br>经验分享:审稿速度还可以,一审三个审稿人,每个人都提出比较犀利的问题,一审修回去的时候,认真回复每一个审稿人的问题,总体上还算快,赶上明年毕业了。 2021.07.02 subit to journal 2021.07.03 received by editor 2021.07.05 reviewer contacted 2021.07.10 in reviewer agreement 2021.07.21 reviews complete 2021.07.27一审回来 2021.09.01 revised 2021.09.23 accept 2021.09.27 online, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210721/35d314b5314d46aba1e20be6d739910e/47473a0e9fe8466c9339b238c83a22d4.jpg, createdBy=6efd5395144, createdName=Jason2021, createdTime=Mon Sep 27 20:54:24 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2130043, encodeId=ee1d2130043af, content=审稿速度:3.0 | 投稿命中率:75.0<br>经验分享:2023.02.01-2023.05.03,三个月接收,审稿人很专业、认真,不错的期刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=31, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKPeeEwPQq9TASVuAByxCR5o85FHJwY4Tiae5lKJUib7yAmric9Gic4wuw6mhEdxX37O8ZOic3fXedyLNQ/132, createdBy=6fb81469253, createdName=mxl7125, createdTime=Thu May 04 13:49:28 CST 2023, time=2023-05-04, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1187443, encodeId=1e06118e44354, content=各位战友:<br>submit 2022-1-10<br>in reviewer agreement 2022-1-10<br>reviews complete 2022-1-23<br>请问一下什么时候可以出一审意见啊? 希望有好运🍀, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=60, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=75925387539, createdName=ms4000000145395898, createdTime=Sun Jan 23 12:31:38 CST 2022, time=2022-01-23, status=1, ipAttribution=)]
    2022-01-23 ms4000000145395898

    各位战友:
    submit 2022-1-10
    in reviewer agreement 2022-1-10
    reviews complete 2022-1-23
    请问一下什么时候可以出一审意见啊? 希望有好运🍀

    3

    展开3条回复
共270条页码: 1/27页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分